DAVANGERE SUGAR COMPANY L·PROCESSED SUGAR 70.18·Diversified FMCG Companies

2026-08-21 NSE BSE Web Result 15 Aug

Price

2.99

+0%
O:3.02
H:3.05
L:2.98
C:2.99

52W Range

2.955.5
+1%/-46%

Market Cap

₹427.57 Cr

Traded: ₹6.55 Cr (1.53%) 0.0x

Free Float: ₹158.50 Cr (4.13% of FF traded)

Volume · 60D trend

2.18 Cr 0.0x

Delivery: % 0.0x

View Delivery Data

Returns

1W:+0% 1M:-6% 3M:-17% 6M:-19% 12M:-22%

Valuation

P/E49.8
P/B0.8
P/S1.7
EV/EBIT87258627.1

Business Strength

ROE2.0%
ROCE5.6%
OPM20.5%
NPM3.8%

Growth (3Y CAGR)

EPS-25.0%
Sales-5.0%
Profit-14.0%
3Y Return-48.0%

Balance Sheet

Debt/Equity0.5
Debt250 Cr
Pledge0.0%
CWIP/Fixed Asset0.0%

Cash Position

CFO/NP-522.2%
FCF-47.3 Cr
FCF 3Y Avg-74.9 Cr
Cash/MCap1.0%

Others

Div Yield0.0%
Div Payout0.0%
Cash Conv. Cycle544 days
Tradeable Free Float37.1%

MTF Exposure Trend

60 sessions · funded amount, % of FF, daily delta

Current
₹ 3.70 Cr
2.33% FF
60d high
₹ 3.85 Cr
60d low
₹ 87.98 L
60d mean
₹ 3.01 Cr
vs mean
▲ 22.86%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
Sales
--
+11.0%
-5.0%
--
+29.0%
Stable
ROE
+2.0%
+3.0%
+3.0%
--
--
Stable
Return
--
+2.0%
-48.0%
-3.0%
--
Stable
Profit
--
+28.0%
-14.0%
--
-28.0%
Decelerating

Quarterly Results

Jun 2026

15 Aug
Rev
35 Cr
+44% YoY-59% QoQ
OPM32.1%
NPM2.7%
PAT
-28% YoY1 Cr
EPS
+0% YoY0.0

Mar 2026

PDF
Rev
84 Cr
+47% YoY+1% QoQ
OPM10.1%
NPM2.3%
PAT
+1% YoY2 Cr
EPS
+0% YoY0.0

Dec 2025

PDF
Rev
83 Cr
+13% YoY+72% QoQ
OPM16.2%
NPM3.2%
PAT
-61% YoY3 Cr
EPS
-60% YoY0.0

Sep 2025

PDF
Rev
48 Cr
+23% YoY+100% QoQ
OPM31.9%
NPM5.5%
PAT
+104% YoY3 Cr
EPS
+100% YoY0.0

Jun 2025

PDF
Rev
24 Cr
-47% YoY-58% QoQ
OPM47.3%
NPM5.4%
PAT
+38% YoY1 Cr
EPS
+0% YoY0.0

Mar 2025

PDF
Rev
57 Cr
-10% YoY-22% QoQ
OPM17.0%
NPM3.4%
PAT
-57% YoY2 Cr
EPS
-67% YoY0.0

Dec 2024

PDF
Rev
73 Cr
-7% YoY+86% QoQ
OPM24.9%
NPM9.3%
PAT
+21% YoY7 Cr
EPS
+25% YoY0.1

Sep 2024

PDF
Rev
39 Cr
+46% YoY-14% QoQ
OPM37.1%
NPM3.3%
PAT
+33% YoY1 Cr
EPS
+0% YoY0.0

Jun 2024

PDF
Rev
46 Cr
-5% YoY-28% QoQ
OPM20.8%
NPM2.1%
PAT
-15% YoY1 Cr
EPS
+0% YoY0.0

Mar 2024

PDF
Rev
64 Cr
-28% YoY-19% QoQ
OPM16.8%
NPM7.2%
PAT
-47% YoY5 Cr
EPS
-50% YoY0.0

Dec 2023

PDF
Rev
78 Cr
--+191% QoQ
OPM20.3%
NPM7.2%
PAT
+144% YoY6 Cr
EPS
--0.0

Sep 2023

PDF
Rev
27 Cr
---44% QoQ
OPM42.6%
NPM3.6%
PAT
-36% YoY1 Cr
EPS
--0.0

Jun 2023

PDF
Rev
48 Cr
---46% QoQ
OPM15.2%
NPM2.3%
PAT
+34% YoY1 Cr
EPS
--0.0

Mar 2023

PDF
Rev
88 Cr
----
OPM20.9%
NPM9.7%
PAT
+191% YoY9 Cr
EPS
--0.1

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity0.50
Interest Coverage-2.8x
Promoter Pledge0.0%
Borrowings250 Cr

Efficiency

Receivable Days54 days
Inventory Days530 days
Payable Days40 days
Cash Conversion cycle544 days

Cash Position

Operating Cash Flow-47 Cr
Investing Cash Flow-1 Cr
Financing Cash Flow51 Cr
Free Cash Flow-47 Cr

Detailed Financials

Jun 2026PDF ↗
Mar 2026PDF ↗
Dec 2025PDF ↗
Sep 2025PDF ↗
Jun 2025PDF ↗
Mar 2025PDF ↗
Dec 2024PDF ↗
Sep 2024PDF ↗
Jun 2024PDF ↗
Mar 2024PDF ↗
Dec 2023PDF ↗
Sep 2023PDF ↗
Jun 2023PDF ↗
Mar 2023PDF ↗
Sales3584834824577339466478274888
Expenses2475693313475525365362154070
Operating Profit1181315111018159111611718
OPM %32.1%10.1%16.2%31.9%47.3%17.0%24.9%37.1%20.8%16.8%20.3%42.6%15.2%20.9%
Other Income0111010002104-1
Interest756974810557773
Depreciation33333433333332
Profit Before Tax115322721572111
Tax %27.3%-38.6%41.9%21.0%24.4%13.3%9.4%28.1%30.7%0.9%18.8%37.0%21.3%25.3%
Net Profit12331271156119
Exceptional Items----------------------------
EPS (Rs)0.00.00.00.00.00.00.10.00.00.00.00.00.00.1
Sales Growth (YoY)44.3%47.3%13.0%22.5%-47.2%-10.5%-6.5%46.1%-4.5%-27.9%--------
Sales Growth (QoQ)-58.6%1.4%71.6%100.2%-57.7%-22.2%86.1%-13.7%-28.3%-18.8%190.9%-43.6%-45.8%--
OP Growth (YoY)-2.0%-12.8%-26.4%5.3%20.3%-9.3%14.4%27.2%30.4%-42.2%--------
OP Growth (QoQ)32.2%-37.1%-12.8%34.9%17.7%-46.9%24.8%54.2%-11.2%-33.0%38.7%58.1%-60.7%--
Profit Growth (YoY)-27.7%0.5%-61.3%103.9%38.3%-57.4%20.7%33.0%-14.6%-46.9%143.9%-36.2%34.1%190.5%
EPS Growth (YoY)0.0%0.0%-60.0%100.0%0.0%-66.7%25.0%0.0%0.0%-50.0%--------
EPS Growth (QoQ)0.0%-50.0%0.0%100.0%0.0%-80.0%400.0%0.0%-66.7%-25.0%300.0%0.0%-83.3%--
OP Margin32.1%10.1%16.2%31.9%47.3%17.0%24.9%37.1%20.8%16.8%20.3%42.6%15.2%20.9%
Net Margin2.7%2.3%3.2%5.5%5.4%3.4%9.3%3.3%2.1%7.2%7.2%3.6%2.3%9.7%
Material Cost %--80.0%67.0%34.0%26.0%61.0%59.0%33.0%61.0%71.0%64.0%-9.0%58.0%59.0%
Employee Cost %--3.0%3.0%4.0%8.0%2.0%4.0%5.0%5.0%3.0%4.0%7.0%4.0%3.0%
P/S1.711.80------------------------
P/E49.8350.17------------------------
P/B0.850.85------------------------

Shareholding Pattern

Shareholders:1.8L (+1706.8%)
Current MixJun 2026

Exchange Filings

50
Company Update21 Aug 2026

Intimation for Newspaper Publication of Notice of the Annual General Meeting ("AGM") of the Company scheduled to be held on September 12, 2026 at 11:00 A.M. (IST).

Others20 Aug 2026

Annual Report for FY 2025-26.

AGM/EGM20 Aug 2026

Notice of 55th Annual General Meeting to be held on September 12, 2026.

Company Update15 Aug 2026

Newspaper publication of the Unaudited Financial Results for the quarter ended June 30, 2026

Result14 Aug 2026

Unaudited financial results for the quarter ended June 30, 2026 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting14 Aug 2026

Outcome of the Board Meeting held on August 14, 2026 for consideration and approval of unaudited financial results for the quarter ended June 30, 2026 and issue of convertible warrants.

Board Meeting11 Aug 2026

Davangere Sugar Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....

Others05 Aug 2026

Re-appointment of M/s. D G M S and Co., Chartered Accountants, as Statutory Auditors of the Company for a period of five consecutive years commencing from the conclusion of 55th Annual ....

Others25 Jul 2026

Investment in Wholly Owned Subsidiary.

Board Meeting23 Jul 2026

Davangere Sugar Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 ,inter alia, to consider and approve the proposal for raising ....

Company Update09 Jul 2026

Outcome of Board Meeting- Allotment of Unsecured Foreign Currency Convertible Bonds.

Company Update09 Jul 2026

Attached the letter informing that the company has listed its FCCB on the Afrinex Stock Exchange, Mauritius.

Company Update08 Jul 2026

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026.

Company Update08 Jul 2026

FCCB offering was fully subscribed in terms of offering circular

Board Meeting03 Jul 2026

Out come Board Meeting held on 03rd July 2026 for Approval of Issue of FCCB

Board Meeting03 Jul 2026

Out come Board Meeting held on 03rd July 2026 for Approval of Issue of FCCB

Company Update30 Jun 2026

The Board Meeting to be held on 02/07/2026 has been revised to 03/07/2026 The Board Meeting to be held on 02/07/2026 has been revised to 03/07/2026

Board Meeting29 Jun 2026

Davangere Sugar Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/07/2026 ,inter alia, to consider and approve the proposal for the ....

Insider Trading / SAST26 Jun 2026

Intimation of closure of trading window for the quarter ended June 30, 2026.

Company Update24 Jun 2026

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform that the Company has received in-Principle approval for FCCBs. Further, the company has Incorporated a 100% ....

Company Update01 Jun 2026

Newspaper publication of the Audited Financial Results for the quarter and year ended March 31, 2026.

Company Update30 May 2026

Please find attached the Annual Secretarial Compliance Report for the Financial year ending March 31, 2026.

Board Meeting29 May 2026

Board Meeting held for approval of Audited Financial Results for the quarter and year ended March 31, 2026.

Result29 May 2026

Audited Financial Results for the quarter and year ended March 31, 2026.

Board Meeting25 May 2026

Davangere Sugar Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve To consider and approve ....

Company Update18 May 2026

Appointment of Mr. Vishwanath Patil as the Company secretary and Compliance Officer of the Company wef 18th May, 2026.

Company Update15 May 2026

Resignation of Ms. Uma Singh from the position of Company Secretary and Compliance Officer of the Company w.e.f. 15th May, 2026.

AGM/EGM27 Apr 2026

Voting Results of the EOGM along with Scrutinizer''s Report

AGM/EGM24 Apr 2026

Submission of Summary of the proceedings of the Extra-Ordinary General Meeting held on 24th April, 2026.

Company Update15 Apr 2026

Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

Company Update10 Apr 2026

Stock Exchange approved Company''s application for reclassification made under Regulation 31A of SEBI (LODR) Regulations, 2015.

Company Update03 Apr 2026

Newspaper advertisement for dispatch of Notice of Extra Ordinary General Meeting of the Company.

AGM/EGM02 Apr 2026

Notice of Extraordinary General Meeting scheduled to be held on April 24, 2026.

Board Meeting30 Mar 2026

Detailed outcome is attached.

Company Update30 Mar 2026

Expansion of Company''s distillery production capacity.

Insider Trading / SAST26 Mar 2026

Intimation for closure of Trading window for the quarter and year ended March 31, 2026.

Board Meeting25 Mar 2026

Davangere Sugar Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 ,inter alia, to consider and approve Raising of funds, in ....

Insider Trading / SAST25 Mar 2026

Intimation of Closure of Trading Window- Fund Raising.

Company Update12 Feb 2026

Newspaper Publications of the Extract of Unaudited Financial Results for the quarter and nine months ended December 31, 2025.

Company Update11 Feb 2026

Please find enclosed a correction to the subject line of the covering letter filed under Results- Outcome of Unaudited Financial Results for the period ended December 31, 2025.

Company Update11 Feb 2026

Monitoring Agency Report for the quarter ended December 31, 2025 issued by CARE Ratings Limited.

Company Update10 Feb 2026

Appointment of B N Rajendrababu, Chartered Accountant as Internal Auditor of the Company

Result10 Feb 2026

Unaudited Financial Results for quater ended 31 December 2025

Board Meeting10 Feb 2026

Unaudited Financial results for qurter and nine months ended 31st December 2025 and appointment of Internal Auditor

Board Meeting05 Feb 2026

Davangere Sugar Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve the un-audited financial ....

Insider Trading / SAST30 Jan 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arihant Capital Markets Ltd

Insider Trading / SAST22 Jan 2026

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arihant Capital Markets Ltd

Company Update17 Jan 2026

This is in response to the emails dated January 16, 2026 received from NSE and BSE, Seeking clarification on the significant movement in the price of the Company''s securities in the recent past.

Insider Trading / SAST17 Jan 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arihant Capital Markets Ltd

Company Update17 Jan 2026

The Exchange has sought clarification from Davangere Sugar Company Ltd on January 16, 2026 with reference to significant movement in price, in order to ensure that investors have latest ....

BSE

Annual Reports

5

2025

2024

2023

2022

2021

Credit Ratings

6
careRating update
05 Mar 2025Report
careRating update
14 Mar 2024Report
careRating update
03 Feb 2023Report
careRating update
09 Mar 2021Report
careRating update
09 Mar 2021Report
careRating update
02 Jul 2020Report

Concalls

1

Aug 2025

31 Aug 2025